YILDIRIM, M. E. Et Al. 2016. Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer. International Journal of Clinical and Experimental Pathology , vol.9, no.10 , 10746-10750.

YILDIRIM, M. E., KILIÇGÜN, H., Kurtulgan, H. K., KARAKUŞ, S., Ersan, S., BAKIR, S., ... Sezgin, I.(2016). Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer. International Journal of Clinical and Experimental Pathology , vol.9, no.10, 10746-10750.

YILDIRIM, MALİK Et Al. "Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer," International Journal of Clinical and Experimental Pathology , vol.9, no.10, 10746-10750, 2016

YILDIRIM, MALİK E. Et Al. "Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer." International Journal of Clinical and Experimental Pathology , vol.9, no.10, pp.10746-10750, 2016

YILDIRIM, M. E. Et Al. (2016) . "Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer." International Journal of Clinical and Experimental Pathology , vol.9, no.10, pp.10746-10750.

@article{article, author={MALİK EJDER YILDIRIM Et Al. }, title={Role of MTHFR gene polymorphisms, serum tissue inhibitor of metalloproteinases-1, thymus chemokine-1 and thrombospondin-1 in endometrial cancer}, journal={International Journal of Clinical and Experimental Pathology}, year=2016, pages={10746-10750} }